Stephens Inc. AR raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.3% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 42,446 shares of the healthcare conglomerate’s stock after acquiring an additional 525 shares during the quarter. Stephens Inc. AR’s holdings in UnitedHealth Group were worth $24,817,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently bought and sold shares of the business. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth $27,000. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. Macroview Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares during the period. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth $32,000. Finally, Delos Wealth Advisors LLC lifted its stake in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the company. Robert W. Baird upped their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. TD Cowen upped their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Wells Fargo & Company upped their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Stephens decreased their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, Argus increased their price target on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $615.53.
UnitedHealth Group Stock Up 0.3 %
Shares of UNH opened at $564.40 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The stock’s 50 day moving average is $582.30 and its two-hundred day moving average is $540.65. The firm has a market cap of $521.18 billion, a P/E ratio of 36.77, a PEG ratio of 1.65 and a beta of 0.58.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the business posted $6.56 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. UnitedHealth Group’s payout ratio is 54.72%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Top Nuclear Stocks Thriving on Soaring Energy Demand
- Ride Out The Recession With These Dividend Kings
- Apple Earnings – When Really Good Just Isn’t Good Enough
- How to Invest in the FAANG Stocks
- Starbucks Stock Primed for Growth Under New CEO Niccol’s Vision
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.